Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Total Non-Current Liabilities (2018)

Dianthus Therapeutics (DNTH) has 1 years of Total Non-Current Liabilities data on record, last reported at $1.2 million in Q4 2018.

  • For Q4 2018, Total Non-Current Liabilities changed N/A year-over-year to $1.2 million; the TTM value through Dec 2018 reached $1.2 million, changed N/A, while the annual FY2018 figure was $1.2 million, N/A changed from the prior year.
  • Total Non-Current Liabilities reached $1.2 million in Q4 2018 per DNTH's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.2 million in Q4 2018 and bottomed at $796000.0 in Q2 2018.